Management Team


Greg D. Casciaro – President & CEO

Gregory D. Casciaro has over 28 years of medical device experience, 23 of those years in the cardiovascular space and leadership positions in both public and private companies. Prior to joining AccessClosure, Inc., he was the President and CEO of XTENT Inc, (XTNT), a revolutionary drug-eluting stent platform. Prior to XTENT, Greg was the President and CEO of Orquest Inc., a private company manufacturing and selling bio-therapeutic products to the orthopedic market. Orquest was acquired by DePuy Acromed, a division of Johnson and Johnson. Prior to that, he was President and CEO of General Surgical Innovations (GSII) which was acquired by US Surgical, a division of Tyco (TYC). He has held several senior level positions with Devices for Vascular Intervention, a division of Guidant Corporation (GDT), and North American Instrument Corporation. In addition to his operating roles, Greg is on the Board of Directors for Trireme Medical Inc, and a former Director at Kerberos, acquired by FoxHollow Technologies, and a former Director with AngioDynamics (ANGO). Greg graduated from Marquette University in Milwaukee, WI with a B.A. in Business Administration.

John J. Buckley – Chief Financial Officer
Prior to joining AccessClosure, John J. Buckley was CFO at Acologix, Inc., a biotechnology company focused on osteo-renal diseases, where he was responsible for all finance and accounting functions, corporate planning, tax, treasury operation, corporate development and risk management. Prior to Acologix, John was a Partner with JWB Partners, CFO of The Dr. Spock Company and was with Ernst & Young LLP most recently as a Partner and as the Director of the Pacific Northwest Life Science Practice. John received his B.B.A. in accounting from the University of Wisconsin­­-Whitewater and is a Certified Public Accountant.

Jim Fortune – Chief Operating Officer
Jim has more than 25 years of operating experience with both public and private companies across the medical device industry. Prior to joining AccessClosure, Jim held COO positions with Confluent Surgical (acquired by Tyco Healthcare) and Intrinsic Therapeutics. He also spent 17 years in various senior management roles with Johnson & Johnson's orthopedic and neurosurgical business units. Jim has a B.S. in mechanical engineering from Renssalaer Polytechnic Institute.

Susan Aloyan – Executive Vice President, Regulatory and Quality Affairs
Susan Aloyan brings over 20 years of experience in domestic and international regulatory affairs to the AccessClosure executive team.Susan was previously the Vice President of Regulatory Affairs for Conceptus and helped bring numerous first in-category devices to market. Prior to joining Conceptus, Susan served as Corporate Director, Regulatory Affairs, Quality Assurance and Clinical Affairs with Gynecare/J&J. She was responsible for approval of the Essure permanent birth control device, as well as Gynecare’s ThermaChoice product. Susan also has been responsible for regulatory submissions at CardioGenesis Corporation and Syntex Corporation. Susan has a B.S. in Management from Golden Gate University and a M.A. in Organizational Management from University of Phoenix.

Michael Devine Executive Vice President, Sales and Marketing
Prior to joining AccessClosure, Michael Devine was the President, North America for TSC, Inc. a global manufacturer of rapid infusion systems and products to prevent hypothermia, where he was responsible for building the commercial strategy for North America. Prior to TSC, Inc., he served as the Vice President of Sales and Marketing for Confluent Surgical, an Incept company that was acquired by Tyco Healthcare. Prior to Confluent Surgical, Michael spent 16 years with Smiths Medical where he held a variety of sales, marketing and general management roles including Vice President & General Manager of Bivona Medical Technologies and President of Level 1, Inc. Subsequently, Smiths Medical consolidated their portfolio of companies and he was named the Vice President of Sales and Corporate Contracts for the combined entity. Michael received a B.S. in Business Administration from California State University, Northridge and an MBA from Northeastern University.

Brian Armijo – Vice President, Operations
Prior to joining AccessClosure, Brian Armijo was the Vice President of Operations for Boston Scientific, Vascular Protection. There he was brought in at the early stages of the BSC acquisition of Embolic Protection, Inc. (EPI) where he successfully built and led the operations organization. Brian's previous roles in medical startups include: Director of Operations at Quanam Medical (through BSC acquisition), Director of Manufacturing at Somnus Medical, and finally Manager of Manufacturing at Arthrocare Corporation. Brian learned much of his craft through various technical leadership roles in the Manufacturing Management Program (MMP) at General Electric. He holds a dual degree from Brown University - a B.S. in electrical engineering-control systems and a B.A. in comparative literature, Spanish.

Mike MacKinnon – Vice President, Sales
Mike MacKinnon joined AccessClosure in October 2006. Prior to joining AccessClosure, he was an Area Director of Sales at FoxHollow Technologies. Mike has 15 years of sales experience in the high tech and medical device industries. He spent four years at StorageTek prior to FoxHollow in the Strategic Sales Division. Prior to StorageTek, Mike held various sales and sales management positions in a number of high-growth tech companies. Mike has a B.S. in business administration from the University of Massachusetts-Lowell.

Andy Uchida – Vice President, Research and Development
Andy Uchida brings over 10 years of experience in medical device operations and research and development roles. Most recently, Andy was a Senior Director of Research and Development at FoxHollow Technologies where he and his team were responsible for the launch of several product line enhancements. Prior to joining FoxHollow, Andy was a Senior Manager of Research and Development at ORATEC Interventions in the spine products group. Prior to his medical device experience, Andy held systems engineering and research and development positions in the semiconductor and electronics industries. Andy holds a B.S. in mechanical engineering from California Polytechnic State University, San Luis Obispo and an MBA from University of California at Berkeley .